search
Back to results

MEsh FIxation in Laparoendoscopic Repair of Large M3 Inguinal Hernias (MEFI)

Primary Purpose

Hernia, Inguinal, Hernia, Direct Inguinal

Status
Recruiting
Phase
Not Applicable
Locations
Poland
Study Type
Interventional
Intervention
Non-fixation of the mesh
Fixation of the mesh
Sponsored by
Swissmed Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Hernia, Inguinal focused on measuring hernia, tapp, inguinal hernia, laparoendscopic repair, groin hernia, mesh

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: elective groin hernia repair, M3 or M3+L1-3 (EHS classification) groin hernia confirmed during surgery eligibility to laparoendoscopic repair written informed consent Exclusion Criteria: emergency surgery (incarcerated hernia) contaminated surgical field recurrent hernia extremely large scrotal hernia with the need of other forms of prevention of Abdominal Compartment Syndrome (botox injection, preoperative progressive pneumoperitoneum - PPP, bowel resection etc.)

Sites / Locations

  • Swissmed HospitalRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Experimental

Arm Label

FIXATION

NON-FIXATION

Arm Description

Lightweight macroporous mesh at least 15x10cm will be placed in preperitoneal space and fixated with use of histoacryl glue. Mesh - B Braun® Optilene Mesh® or BD® SoftMesh® Glue - Histoacryl® LapFix

Standard, 3-D, anatomical mesh will be placed in preperitoneal space without the use of fixating materials. Mesh - BD® 3D Max® Mesh or Medtronic® Dextile Anatomical Mesh®

Outcomes

Primary Outcome Measures

Reccurence Rate
Reccurence in 1 year after surgery

Secondary Outcome Measures

Full Information

First Posted
December 26, 2022
Last Updated
April 11, 2023
Sponsor
Swissmed Hospital
Collaborators
Klinika Chirurgii Ogólnej, Onkologicznej i Endokrynologicznej Szpitala Zespolonego w Kielcach, Oddział Chirurgii Ogólnej MCM Jonscher w Łodzi, Oddział Chirurgii Ogólnej i Onkologicznej Szpitala w Wejherowie, Klinika Chirurgii Ogólnej i Onkologicznej UM w Łodzi, Oddział Chirurgii Ogólnej, Małoinwazyjnej i Wieku Podeszłego Miejskiego Szpitala Zespolonego w Olsztynie, Oddział Chirurgii Ogólnej Regionalnego Centrum Zdrowia w Lubinie, Klinika Chirurgii Ogólnej, Wojskowy Instytut Medycyny Lotniczej w Warszawie, Oddział Chirurgii Ogólnej, SPOZ w Siedlcach, Oddział Chirurgii Ogólnej Szpitala w Puszczykowie, Oddział Chirurgii Ogólnej z Pododdziałem Urazowo-Ortopedycznym Szpitala w Szczytnie
search

1. Study Identification

Unique Protocol Identification Number
NCT05678465
Brief Title
MEsh FIxation in Laparoendoscopic Repair of Large M3 Inguinal Hernias
Acronym
MEFI
Official Title
MEsh FIxation in Laparoendoscopic Repair of Large M3 Inguinal Hernias - Multicenter, Double-blinded, Randomized Controlled Trial.
Study Type
Interventional

2. Study Status

Record Verification Date
April 2023
Overall Recruitment Status
Recruiting
Study Start Date
February 1, 2023 (Actual)
Primary Completion Date
February 1, 2024 (Anticipated)
Study Completion Date
February 1, 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Swissmed Hospital
Collaborators
Klinika Chirurgii Ogólnej, Onkologicznej i Endokrynologicznej Szpitala Zespolonego w Kielcach, Oddział Chirurgii Ogólnej MCM Jonscher w Łodzi, Oddział Chirurgii Ogólnej i Onkologicznej Szpitala w Wejherowie, Klinika Chirurgii Ogólnej i Onkologicznej UM w Łodzi, Oddział Chirurgii Ogólnej, Małoinwazyjnej i Wieku Podeszłego Miejskiego Szpitala Zespolonego w Olsztynie, Oddział Chirurgii Ogólnej Regionalnego Centrum Zdrowia w Lubinie, Klinika Chirurgii Ogólnej, Wojskowy Instytut Medycyny Lotniczej w Warszawie, Oddział Chirurgii Ogólnej, SPOZ w Siedlcach, Oddział Chirurgii Ogólnej Szpitala w Puszczykowie, Oddział Chirurgii Ogólnej z Pododdziałem Urazowo-Ortopedycznym Szpitala w Szczytnie

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The goal of this Multicenter Clinical Trial is to verify the hypothesis that non-fixation of the 3-D anatomical mesh (Dextile Anatomical Mesh or 3D Max Mesh) is non-inferior in terms of recurrence compared to fixation of lightweight, macroporous meshes in laparoendoscopic repairs of large M3 inguinal hernias.
Detailed Description
INTRODUCTION International guidelines of groin hernia treatment strongly recommends to fixate the mesh in case of large M3 medial defects during laparoendoscopic approach (TAPP / TEP). Main purpose of fixation is to decrease recurrence rate which is alarmingly high in case of those defects. Recommendation was based on analysis of large German database (Herniamed). However, deeper look into those findings shows that most of TAPP and TEP procedures were performed with the use of lightweight, flat, macroporous meshes. In 2022 multidisciplinary team consisting of hernia surgeons and scientists from universities of technology conducted an experimental study with the use of 3d groin model to confirm or deny the hypothesis that fixation is not necessary in above cases. Study was conducted with the use of all 3-D anatomical meshes available on Polish market, as well as with flat, macroporous implants. Experiment showed that large, rigid and anatomically shaped meshes are able to maintain its position in groin without need of fixation. To confirm experimental results we decided to conduct large, multicentre, clinical study to evaluate necessity of mesh fixation of large, spatial, standard polypropylene implants. STUDY HYPOTHESIS Non-fixation of spatial, standard polypropylene meshes is non-inferior as compared to fixation of flat, polypropylene lightweight meshes during TAPP / TEP procedures. MATERIALS AND METHODS 11 large surgery centres in Poland having proficiency in laparoendoscopic groin hernia repairs (performing at least 80 TAPP/TEP a year) were recruited for this study. Before recruiting patients a two day "bootcamp" meeting was planned. Each centre designated one surgeon responsible for conducing the trial in its hospital and sent him/her to meeting. Recurrence rate in 12-month follow-up was set as a primary endpoint. Pain sensation (assessed with VAS scale) was made a secondary endpoint. Statistical analysis was performed by experts to adjust the sample sizes. The trial was planned as non-inferiority study with test power = 80%, p-value = 0,05 and threshold for clinical significance = 8%. Percentage loss was assumed at 10%. Recurrence rate was assumed 4% based on literature. Based on those assumptions minimal sample size in both arms was calculated at 83-102. Inclusion criteria: elective groin hernia repair, age > 18 years, male and female patients can participate, M3 or M3+L1-3 (EHS classification) groin hernia confirmed during surgery, eligibility to laparoendoscopic repair, written informed consent. Exclusion criteria: age <18 years, emergency surgery (incarcerated hernia), contaminated surgical field, extremely large scrotal hernia with the need of other forms of prevention of ACS (preoperative botox injection, bowel resection etc.) First arm (control group) will consist of patients repaired with the use of flat, macroporous, lightweight mesh fixated with histoacryl glue. Second arm will consist of patients repaired with the use of anatomically shaped, large, standard, polypropylene mesh (Dextile Anatomical Mesh - MEDTRONIC or 3D Max Mesh - BD) without the use of fixation material. As M3 hernias are difficult to diagnose before the surgery, all patients planned for laparoendscopic repairs will be asked to participate in trial. During the surgery, when the defect size is measured, patient will be fully included in the study. After dissection of preperitoneal space (and establishing crucial checkpoints), surgeon will open envelope and find out the technique he will have to perform. Patients won't be aware of the method used during surgery. Unblinding will take place at the end of the trial. Pain will be measured during the hospital stay and then 7-days, 3-months and 12-months after surgery (VAS Scale). Follow up will be performed by Medical Assistant via phone call (also blinded to the method used). If any doubts occur, patient will be asked to come to ambulatory visit. PREDICTED OUTCOMES Based on experimental study published in Surgical Endoscopy (Zamkowski et al., 2022) and own experience, we believe that recurrence rate in both arms will be on the same level. Those outcomes will be a strong argument for amending the guidelines in terms of mesh fixation. It would show that mesh fixation is not necessary if the proper, spatial mesh is used.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hernia, Inguinal, Hernia, Direct Inguinal
Keywords
hernia, tapp, inguinal hernia, laparoendscopic repair, groin hernia, mesh

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Patients in both arms will recieve intervention. First arm (mesh + fixation) serves also as control. Patients in second arm will be operated with mesh without fixation.
Masking
ParticipantInvestigatorOutcomes Assessor
Masking Description
Double-blinded (surgeon/patient)
Allocation
Randomized
Enrollment
204 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
FIXATION
Arm Type
Experimental
Arm Description
Lightweight macroporous mesh at least 15x10cm will be placed in preperitoneal space and fixated with use of histoacryl glue. Mesh - B Braun® Optilene Mesh® or BD® SoftMesh® Glue - Histoacryl® LapFix
Arm Title
NON-FIXATION
Arm Type
Experimental
Arm Description
Standard, 3-D, anatomical mesh will be placed in preperitoneal space without the use of fixating materials. Mesh - BD® 3D Max® Mesh or Medtronic® Dextile Anatomical Mesh®
Intervention Type
Procedure
Intervention Name(s)
Non-fixation of the mesh
Other Intervention Name(s)
3D Max Mesh (BD), Dextile Anatomical Mesh (Medtronic)
Intervention Description
3D-shaped, anatomical, standard, polypropylene mesh without fixation.
Intervention Type
Procedure
Intervention Name(s)
Fixation of the mesh
Other Intervention Name(s)
B Braun Optilene Mesh, BD SoftMesh
Intervention Description
Glue fixation of lightweight, macroporous, polypropylene mesh.
Primary Outcome Measure Information:
Title
Reccurence Rate
Description
Reccurence in 1 year after surgery
Time Frame
12-months
Other Pre-specified Outcome Measures:
Title
Pain score
Description
Pain sensation using Pain Visual Analog Scale (VAS)
Time Frame
7-days, 3-months, 12-months
Title
Other complications
Description
Other surgical complications (seroma, hematoma, surgical site infections - SSI etc.)
Time Frame
7-days, 3-months, 12-months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: elective groin hernia repair, M3 or M3+L1-3 (EHS classification) groin hernia confirmed during surgery eligibility to laparoendoscopic repair written informed consent Exclusion Criteria: emergency surgery (incarcerated hernia) contaminated surgical field recurrent hernia extremely large scrotal hernia with the need of other forms of prevention of Abdominal Compartment Syndrome (botox injection, preoperative progressive pneumoperitoneum - PPP, bowel resection etc.)
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Mateusz Zamkowski, MD, PhD
Phone
+48 504 236 036
Email
zamek@wp.eu
First Name & Middle Initial & Last Name or Official Title & Degree
Magda Halska
Phone
+ 48 607 870 690
Email
worldofsurge@gmail.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Mateusz Zamkowski, MD, PhD
Organizational Affiliation
Swissmed Hospital
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Maciej Śmietański, Prof.
Organizational Affiliation
Swissmed Hospital
Official's Role
Study Director
Facility Information:
Facility Name
Swissmed Hospital
City
Gdańsk
ZIP/Postal Code
80-280
Country
Poland
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Mateusz Zamkowski, MD, PhD
Phone
+ 48 504 236 036
Email
zamek@wp.eu
First Name & Middle Initial & Last Name & Degree
Magdalena Halska
Phone
+48 607 870 690
Email
worldofsurge@gmail.com
First Name & Middle Initial & Last Name & Degree
Kryspin Mitura, MD, PhD
First Name & Middle Initial & Last Name & Degree
Przemysław Rymkiewicz, MD
First Name & Middle Initial & Last Name & Degree
Sławomir Saluk, MD
First Name & Middle Initial & Last Name & Degree
Michał Romańczuk, MD
First Name & Middle Initial & Last Name & Degree
Marcin Włodarczyk, MD, PhD
First Name & Middle Initial & Last Name & Degree
Aleksander Król, MD, PhD
First Name & Middle Initial & Last Name & Degree
Olaf Mędraś, MD
First Name & Middle Initial & Last Name & Degree
Dominik Górski, MD
First Name & Middle Initial & Last Name & Degree
Paula Franczak, MD
First Name & Middle Initial & Last Name & Degree
Jacek Garbias, MD
First Name & Middle Initial & Last Name & Degree
Przemysław Sroczyński, MD
First Name & Middle Initial & Last Name & Degree
Łukasz Nawacki, MD, PhD
First Name & Middle Initial & Last Name & Degree
Michał Janik, MD, PhD

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
Data will be availble in English on a reasonable request.
IPD Sharing Time Frame
Data will be availble in English on a reasonable request.
IPD Sharing Access Criteria
Access to trial IPD can be requested by qualified researchers engaging in independent scientific research, and will be provided following review and approval of a research proposal and Statistical Analysis Plan (SAP) and execution of a Data Sharing Agreement (DSA). For more information or to submit a request, please contact.
Citations:
PubMed Identifier
36229552
Citation
Zamkowski M, Tomaszewska A, Lubowiecka I, Karbowski K, Smietanski M. Is mesh fixation necessary in laparoendoscopic techniques for M3 inguinal defects? An experimental study. Surg Endosc. 2023 Mar;37(3):1781-1788. doi: 10.1007/s00464-022-09699-5. Epub 2022 Oct 13.
Results Reference
background
PubMed Identifier
29330835
Citation
HerniaSurge Group. International guidelines for groin hernia management. Hernia. 2018 Feb;22(1):1-165. doi: 10.1007/s10029-017-1668-x. Epub 2018 Jan 12.
Results Reference
background
PubMed Identifier
26886454
Citation
Mayer F, Niebuhr H, Lechner M, Dinnewitzer A, Kohler G, Hukauf M, Fortelny RH, Bittner R, Kockerling F. When is mesh fixation in TAPP-repair of primary inguinal hernia repair necessary? The register-based analysis of 11,230 cases. Surg Endosc. 2016 Oct;30(10):4363-71. doi: 10.1007/s00464-016-4754-8. Epub 2016 Feb 17.
Results Reference
background
PubMed Identifier
35213495
Citation
Novik B, Sandblom G, Ansorge C, Thorell A. Association of Mesh and Fixation Options with Reoperation Risk after Laparoscopic Groin Hernia Surgery: A Swedish Hernia Registry Study of 25,190 Totally Extraperitoneal and Transabdominal Preperitoneal Repairs. J Am Coll Surg. 2022 Mar 1;234(3):311-325. doi: 10.1097/XCS.0000000000000060.
Results Reference
background

Learn more about this trial

MEsh FIxation in Laparoendoscopic Repair of Large M3 Inguinal Hernias

We'll reach out to this number within 24 hrs